Lumentum (LITE) is trading at $565.58, below its short- and medium-term moving averages, while derivatives positioning shows elevated long bias alongside outright selling pressure. The latest quart...
Lumentum (LITE) closed at $565.58, down 2.84% on the day, after trading in a 24-hour range of $598.23 to $562.28. The stock is sitting well below its 7-day SMA of $597.98, 20-day SMA of $666.18, and 50-day SMA of $833.51, which leaves the short- and medium-term trend aligned to the downside. The current setup is not a clean trend reversal; it is a low-volume pullback at 0.31x of the 5-day average, which can help stabilize price, but only if buyers can reclaim lost moving averages.
On November 2, 2026, Lumentum reported first-quarter fiscal 2027 net revenue of $1.26 billion, with GAAP gross margin at 51.0% and non-GAAP gross margin at 53.2%. It also guided second-quarter fiscal 2027 revenue to $1.575 billion to $1.625 billion, with non-GAAP diluted EPS of $5.90 to $6.20 and non-GAAP operating margin of 45.0% to 46.0%. Management said pump lasers and optical circuit switches were the leading contributors and highlighted a second major NPO/CPO win backed by purchase commitments exceeding $5 billion. That matters because it gives the market a real operating backdrop: the debate is no longer whether the business is producing strong numbers, but whether that strength can keep overriding a heavy chart.
Recent coverage has pulled LITE in both directions. UBS cut its target to $686 from $960 and kept a Neutral rating on November 10, while Bernstein raised its target to $700 from $635 and kept Outperform.
Source link







